Psoriatic Arthritis and Psoriasis Treatment Decision Aid (DA)

  • days left to enroll
  • participants needed
  • sponsor
    University of Pennsylvania
Updated on 24 March 2022
psoriasis treatment


The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.


Prior to the interventional study, we will develop a decision aid using design thinking. In this interventional study, we will implement and test a patient-centered decision aid for therapy selection among patients with psoriasis and/or psoriatic arthritis who are starting or switching to a new medication.

Condition Psoriatic Arthritis, Psoriasis
Treatment Decision Aid
Clinical Study IdentifierNCT03737045
SponsorUniversity of Pennsylvania
Last Modified on24 March 2022


Yes No Not Sure

Inclusion Criteria

Age 18 years or older
Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist)
Treated at Penn
In addition to the above, for the observation and implementation phases of the
Initiation of a new psoriasis or psoriatic arthritis treatment
Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation
Patients may be taking other traditional DMARDs
A washout period is not required

Exclusion Criteria

Unable to give informed consent
Youth, under the age of 18 years
Patients without psoriasis or psoriatic arthritis
Not being treated at a Penn clinic
In addition to the above, for the observation and implementation phases of the
Not starting or switching to a new medication
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note